In their review of precision medicine in oncology, Joshi et al. Expert faculty will discuss and analyze the latest scientific findings and practice-changing advances . Genomic testing involves many stakeholders working in a coordinated fashion to deliver high-quality tissue samples to high-quali … cardio-oncology; precision medicine; precision cardio-oncology-omics; cardiotoxicity; The last decade has witnessed a revolution in cancer therapeutics, producing a population of cancer survivors now exceeding 15.5 million in the United States alone ().Although encouraging, this gain in cancer survivorship has also produced a growing cohort of patients with increased cardiovascular complications. National Precision Oncology Program (NPOP) Precision Oncology Program. The program is a component of the VHA's Precision Oncology Initiative, which aims to transform VHA into a system of excellence in oncology care. The complexity of cancer and its treatment. However, clinical outcomes, including survival and the cost of health care associated with precision cancer medicine, have been challenging to measure and . 1 to 5; 2017 to 2021; 2017 to 2021: v.1 2017: v.2 2018: v.3 2019: v.4 2020: v.5 2021: Articles from NPJ Precision Oncology are provided here courtesy of Nature Publishing Group. Please note that the Journal of Radiation Oncology ceased publishing with Springer Nature on December 31 st 2020. Please share this webinar with anyone who may be interested! comprehensively detail evolving strategies in diagnosis, the importance of subtype classification, and novel therapeutic approaches that harness the immune system and target oncogenic driver mutations; this review should be . LPOP is a joint effort between the U.S. Department of Veterans Affairs' (VA's) Office of Research and Development (ORD) and its National Oncology Program Office, with support from the Office of . An overview of precision oncology basket and umbrella trials for clinicians Jay J. H. Park MSc , Experimental Medicine, Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada Impact Factor List of Journals For 2021 by JCR - CA-A CANCER JOURNAL FOR CLINICIANS - 508.7, Nature Reviews Molecular Cell Biology - 98.4, New 1Cancer Center, The First Hospital of Jilin University, Changchun, Jilin 130021, China. Two organoids: The Matrigel-based organoid is at left, but Ankur Singh's team developed a new, improved synthetic hydrogel organoid . . 6 In the United Kingdom, the National Health Service's 2019 Long-Term . Prostate cancer organoids. The JCO Precision Oncology Impact Factor IF measures the average number of citations received in a particular year (2020) by papers published in the JCO Precision Oncology during the two preceding years (2018-2019). JAMA Oncol . 1Small Animal Clinical Sciences, College of Veterinary Medicine, Michigan State University, 736 Wilson Road, East Lansing, MI 48824, USA. About the journal. JCO PO is a peer-reviewed, online-only, article-based journal publishing original research, reports, opinions, and reviews that advance the science and practice of precision oncology and define genomics- and other biomarker-driven clinical care of patients with cancer. Medical Director, Precision Medicine, Geriatric Oncology Consortium; Professor, University of South Florida, College of Pharmacy Dr Howard McLeod is an internationally recognized expert in precision medicine, having made novel contributions at the discovery, translation, implementation, and policy levels. The highest fee charged by this journal is 3170 USD as publication fees (article processing charges or APCs). Evidence-Based Oncology. Precision oncology has tended to focus on the cancer genome, but also taking into account RNA and proteins, for example, could identify new options for targeted treatments. Clinical data and precision medicine: The urgent need for in‑house NGS capabilities at community hospitals. npj Precision Oncology 2397-768X (Online) Website ISSN Portal About; Articles; About. We evaluated variant discordance between and within families with germline TP53 variants in the National Cancer Institute's Li . Precision oncology is the new paradigm in cancer care. Purpose: The advent of genomic diagnostic technologies such as next-generation sequencing has recently enabled the use of genomic information to guide targeted treatment in patients with cancer, an approach known as precision medicine. JCO PO is a peer-reviewed, online-only journal publishing original research, reports, opinions, and reviews that will advance the science and practice of precision oncology and define genomics- and other biomarker-driven clinical care of patients with cancer.. 介绍. JIPO publishes high-quality manuscripts that appeal to a broad readership of healthcare professionals and scientists, especially those with an interest in oncology and immunology. Loxo Oncology at Lilly, a research and development group of Eli Lilly and Company (NYSE: LLY), and Foghorn Therapeutics Inc. (Nasdaq: FHTX), today announced a strategic collaboration to create novel oncology medicines by applying Foghorn's proprietary Gene Traffic Control® platform. The collaboration includes a co-development and co-commercialization agreement for Foghorn's selective BRM . Germline Sequencing Improves Tumor-Only Sequencing Interpretation in a Precision Genomic Study of Patients With Pediatric Solid Tumor November 11th 2021, 5:00pm. To provide state-of-the-art care and grow your reputation within your local and regional market, talk with your Thermo Fisher Account Manager today. In accordance with Npj Precision Oncology's editorial policy, review content is not publicly displayed on Publons. Annals of Oncology is an international journal at the forefront of its field, publishing articles on innovative cancer treatments, translational research relating to oncology and precision medicine. The Journal of Precision Oncology is the official semi-annual Publication of Healthcare Global Enterprises Limited. Credit: Ankur Singh. Innovative and timely scientific and educational content provide a deeper . this conference is one you won't want to miss. Innovative and timely scientific and educational content provide a deeper . Germline Sequencing Improves Tumor-Only Sequencing Interpretation in a Precision Genomic Study of Patients With Pediatric Solid Tumor Received 10 Dec 2019. Visit journal's web site. Understanding of the term "Precision Medicine" is variable. Journal of Precision Oncology On Web:: Online manuscript submission and processing. The journal is now accepting submissions of original research articles, case reports, reviews, editorials and perspectives on all aspects of precision medicine. . 2Rogue Research Inc . The impact score (IS), also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly . Precision oncology still has much room to grow, but research presented at the 2019 ASCO Annual Meeting shows great promise for realizing the vision of caring for every patient by learning from every patient. International in reach and interdisciplinary in content, the Journal of Radiation Oncology publishes original research, clinical investigations, review articles . In the scientific literature and lay press, the relevant discipline is often called personalized, or precision, cancer medicine. Precision oncology still has much room to grow, but research presented at the 2019 ASCO Annual Meeting shows great promise for realizing the vision of caring for every patient by learning from every patient. It provides a single forum for communication among neurologists, neurosurgeons, radiotherapists, medical oncologists, neuropathologists, neurodiagnosticians, and laboratory-based oncologists . Published online December 22, 2021. Precision Medical Sciences is an international and peer-reviewed open access journal that covers all areas of clinical and translational research for precision medicine, especially in the field of oncology. Browse the archive of articles on npj Precision Oncology. npj Precision Oncology is an international, peer-reviewed journal committed to publishing cutting-edge scientific research in all aspects of precision oncology from basic science to translational applications to clinical medicine. Read more. In May 2018, the National Institutes of Health launched their "All of Us" Initiative, which aims to gather demographic and biological data from at least one million people living in the United States to be used for precision care in oncology and other areas of medicine. A multi-institutional team of investigators led by bioengineer Ankur Singh has developed . Find out more. In this Special Series issue, Journal of Clinical Oncology presents a systematic assessment of cancer genomic information and its accelerating clinical impact. Background In 2007, we initiated IMPACT, a precision medicine program for patients referred for participation in early-phase clinical trials. Precision Medicine in Oncology. In accordance with Npj Precision Oncology's editorial policy, review content is not publicly displayed on Publons. Loxo Oncology at Lilly, a research and development group of Eli Lilly and Company (NYSE: LLY), and Foghorn Therapeutics Inc. (Nasdaq: FHTX), today announced a strategic collaboration to create novel oncology medicines by applying Foghorn's proprietary Gene Traffic Control® platform. Evolution of the randomized clinical trial in the era of precision oncology. npj Precision Oncology Key Factor Analysis. Accuracy and Precision of a Veterinary Neuronavigation System for Radiation Oncology Positioning. Precision Oncology: An Overview. Expanded precision medicine capabilities for strengthening oncology drug development at Daiichi Sankyo. Zardavas D , British Journal of Cancer (2014) 111, 1881-1887 This work is licensed under a . The Journal publishes innovative original research articles including translational science and . Precision Detection Technology: Equipping Precision Oncology with Wings. PRECISION ONCOLOGY Awada A, Kourie HR, Blay JY, Harbeck N, Mau-Sørensen PM, Sleijfer S. . But, to drive precision oncology forward, informaticians must be engaged. Annals of Oncology, the journal of the European Society for Medical Oncology and the Japanese Society of Medical Oncology, provides rapid and efficient peer-review publications on innovative cancer treatments or translational work related to oncology and precision medicine. The official journal of the European Society for Medical Oncology and the Japanese Society of Medical Oncology (JSMO). DOI: 10.1200/PO.21.00281 JCO Precision Oncology no. Annals of Oncology, the journal of the European Society for Medical Oncology and the Japanese Society of Medical Oncology, provides rapid and efficient peer-review publications on innovative cancer treatments or translational work related to oncology and precision medicine. A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). Special Issue "The Promise of Precision Oncology in Breast Cancer". Molecular Analysis for Precision Oncology Virtual Congress 202107-09 October 2021 Publication of this Abstract book is supported by the European Society for Medical Oncology Volume 32, Supplement 6, Published online December 22, 2021. Learn More. Oncology has led the field in introducing precision therapies, although a similar approach is now being developed in areas such as neurology and endocrinology. An ISSN is an 8-digit code used to identify newspapers, journals, magazines and periodicals of all kinds and on all media-print and electronic. What Is Precision Oncology? It's the science of using each patient's individual genetics - the genes that are mutated, causing their cancer to grow - to create a treatment protocol just for them, based on those genetic mutations. In this new genomic era of medicine, healthcare professionals need to have a sound working knowledge of not just the PM available and used in practice, but also of the biomarkers . PURPOSE: The use of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology guidelines has improved germline variant classification concordance, but discrepancies persist, sometimes directly affecting medical management. used in precision medicine at the right time for the patient If you are a clinician, research scientist, or regulator …. Please join us for the world's most informative conference for precision medicine leaders. Cancer care is increasingly tailored to individual patients, who can undergo genetic or biomarker testing soon after diagnosis, to determine which treatments have the best chance of shrinking or eliminating tumours. Journal list; Help; Try out PMC Labs and tell us what you think. For clinicians, pharmacists, and clinical pharmacologists, it refers to the right decision (treat or not), right drug, right combination, right timing, and right dose, taking into account the clinical trial data for the patient group being treated and finessing that to the individual biological and pharmacological variables either . 2021;7(5):728-734. doi: 10.1001/jamaoncol.2021.0379 PubMed Google Scholar Crossref Precision Clinical Medicine is now indexed in the Emerging Sources Citation Index. Current issue. Recently, a novel knowledge bank (KB) approach to predict outcomes of individual patients with acute myeloid leukemia (AML) was developed using unbiased machine learning. Building this expertise into your local care team empowers them to make smarter and faster therapy decisions. Cancer is one of the leading causes of death in the United States. JCO PO is a peer-reviewed, online-only, article-based journal publishing original research, reports, opinions, and reviews that advance the science and practice of precision oncology and define genomics- and other biomarker-driven clinical care of patients with cancer. Journal of Gastrointestinal Oncology (JGO) is now a member of Committee on Publication Ethics (COPE) Starting from July 2021, AME Publishing Company is formally recognized a publisher member of Committee on Publication Ethics (COPE) and over 60 AME-published journals become a member of Committee on Publication Ethics (COPE), as part of AME's commitment to best practice in scholarly publishing. The Journal of Neuro-Oncology is a multi-disciplinary journal encompassing basic, applied, and clinical investigations in all research areas as they relate to cancer and the central nervous system. The Journal of Immunotherapy and Precision Oncology (JIPO) is a high-quality, peer-reviewed publication that appeals to a broad readership of healthcare professionals and scientists, especially those with an interest in oncology and immunology. Randomized clinical trials are considered the milestones of clinical research in oncology, and guided the development and approval of new compounds so far. Journal of Precision Oncology, a publication of Healthcare Global Enterprises Ltd, is a peer-reviewed print + online Semiannual journal. Isabelle F. Vanhaezebrouck,1 Elizabeth A. Ballegeer,1 Stephen Frey,2 and Rob Sieffert1. Precision Oncology is an innovative approach to cancer treatment that ensures your treatment is specifically designed and targeted to your unique form of cancer. 5 (2021) 1840-1852. npj Precision Oncology is an international, peer-reviewed journal committed to publishing cutting-edge scientific research in all aspects of precision oncology from basic science to translational applications to clinical medicine. Features of Manuscript Management System Online submission Precision oncology, defined as molecular profiling of tumors to identify targetable alterations, is rapidly developing and has entered the mainstream of clinical practice. About JCO PO. The National Precision Oncology Program (NPOP) is a national program led by the National Oncology Program Office. This cross-journal thematic series of original research and review articles gathers the latest research on precision oncology. Annals of Oncology. Precision medicine (PM) is a medical model that proposes the customization of healthcare, with medical decisions, treatments, practices, or products being tailored to a subgroup of patients, instead of a one‐drug‐fits‐all model. Academic Editor: Guido Bocci. Several important findings have emerged. If you need assistance, please contact the Editorial Office at 703-797-1900 or via email. The 2021 Precision Oncology Summit: Personalizing treatment to improve patient outcomes is a one-day conference featuring leading experts in the field of precision oncology who will provide a comprehensive overview of implications of actionable molecular alterations across common malignancies. Precision Radiation Oncology, also known as the Blue Journal, presents an open access forum of collaboration and exchange for comprehensive and cutting edge-information on basic, translational, and clinical research in radiation oncology. The American Journal of Accountable Care. To validate its prognostic value, we analyzed 1612 adults with de novo AML treated on Cancer and Leukemia Group B front-line trials who had pretreatment clinical, cytogenetics, and mutation data on 81 leukemia/cancer . About the journal. ARCHIVE ISSUES - JUNE 2021. Journal List; NPJ Precis Oncol; NPJ Precision Oncology Vols. We compare these findings with RCTs from prior eras (targeted therapy 2005-2009, and cytotoxic therapy 1995-2004). Article. Rilan Bai,1 Zheng Lv,1 Xiao Chen,1 Hanfei Guo,1 Ling Bai,1 Huimin Tian,1 Wei Li,1 and Jiuwei Cui 1. Journal of Immunotherapy and Precision Oncology | Read 81 articles with impact on ResearchGate, the professional network for scientists. New Research Underscores Need for More Diversity in Precision Oncology Studies. There is a waiver policy for these charges. Published online December 22, 2021. We assessed the correlation of factors, including genomically matched therapy, with overall survival (OS). Deadline for manuscript submissions: 31 December 2021 . PMLS VIRTUAL SERIES 2022 About this Journal. The collaboration includes a co-development and co-commercialization agreement for Foghorn's selective BRM . and is based on the recognition that precision medicine is now a reality in the field of oncology .Current understanding of cancer provides opportunities to understand each cancer, and patient as unique and to tailor make care strategies that cater to this uniqueness while . The impact score (IS) 2020 of JCO Precision Oncology is 2.98, which is computed in 2021 as per its definition.JCO Precision Oncology IS is decreased by a factor of 0.08 and approximate percentage change is -2.61% when compared to preceding year 2019, which shows a falling trend. Please contact the Editor-in-Chief, Jiade J. Lu, M.D., M.B.A. (jiade.lu@sphic.org.cn) to discuss your manuscript. Main focuses of …. is the Director of Precision Oncology. The conference brings together leaders in academia, biotech, pharmaceuticals, diagnostics, clinical research, healthcare and regulatory bodies. Instructions to authors. Del Paggio JC, Berry JS, Hopman WM, et al. JCO Precision Oncology (JCO PO) is a peer-reviewed, online-only journal publishing original research, reports, opinions, and reviews that advance the science and practice of precision oncology and define genomics- and other biomarker-driven clinical care of patients with cancer. Journal of Immunotherapy and Precision Oncology | Read 23 articles with impact on ResearchGate, the professional network for scientists. 5 (2021) 1840-1852. DOI: 10.1200/PO.21.00281 JCO Precision Oncology no. Prostate Cancer Organoids Open Path to Precision Oncology. Precision Cardio-Oncology in ICI-Induced Cardiovascular Toxicity Gene Polymorphisms, Multiple Hits, and Autoimmunity Gene polymorphisms leading to deficiency or dysfunction of CTLA-4, PD-1, or PDL-1 may be associated with myocarditis or cardiomyopathy and other autoimmune or inflammatory conditions in humans or in mice. It focuses on how precision oncology has shaped advances in the impact of non-coding RNAs in epigenetics and cancer, immunotherapy and tumor biology, and the clinical significance of various therapies in a range of cancers. Publishing with this journal. Prostate cancer organoids open path to precision oncology. The official journal of the European Society for Medical Oncology and the Japanese Society of Medical Oncology (JSMO). The official channel of Journal of Immunotherapy and Precision Oncology (www.jipoonline.org) JIPO is an Open access journal that publishes manuscripts with appeal to clinician and scientists with . Although precision oncology has transformed care for a variety of patients, the promise of the practice remains limited to up to 20% of patients with solid tumors, leading researchers to continue . In the last few years, however, molecular and genomic profiling led to a change of paradigm in therapeutic algorithms of many cancer types, with the spread of different biomarker-driven therapies (or targeted therapies). Published online December 22, 2021. ISSN (Online) The ISSN (Online) of npj Precision Oncology is - . Editor's Pick: Precision Medicine in Lung Cancer. In 2018 alone, there will be an estimated 1,735,350 new diagnoses and 609,640 cancer-related deaths 1.Much work is ongoing to better understand and treat this group of diseases. In precision medicine, diagnostic testing is often employed for selecting appropriate and optimal therapies based on the context of a patient's genetic content . In this study, we describe the design and results of oncology RCTs conducted during 2010 to 2020 in the era of precision oncology. The Journal of Precision Oncology aims at building upon the current understanding of cancer in a manner that treats each type of cancer and each patient as a unique case, such that care strategies . Michael Kelley, MD is the Director of the National Oncology Program for the VA. Dr. Sara Ahmed, PhD. Hippocrates (Kos, c.460-c.370 BC) reminds us that "It is more important to know what sort of person has a disease than to know what . JCO PO is a peer-reviewed, online-only, article-based journal publishing original research, reports, opinions, and reviews that advance the science and practice of precision oncology and define genomics- and other biomarker-driven clinical care of patients with cancer. Patients and methods We performed molecular profiling (Clinical Laboratory Improvement Amendments) (genes ≤ 182) for patients with lethal . This special issue belongs to the section " Molecular Oncology ". Innovative and timely scientific and educational content provide a . Annals of Oncology is an international journal at the forefront of its field, publishing articles on innovative cancer treatments, translational research relating to oncology and precision medicine. @article{osti_23065581, title = {How Advances in Imaging Will Affect Precision Radiation Oncology}, author = {Jaffray, David A., E-mail: david.jaffray@rmp.uhn.on.ca and Department of Medical Physics, Princess Margaret Cancer Centre, Toronto, Ontario and Das, Shiva and Jacobs, Paula M. and National Institutes of Health, National Cancer Institute, Bethesda and Jeraj, Robert and Lambin, Philippe . But, to drive precision oncology forward, informaticians must be engaged. Precision Cancer Medicine is an open access, peer-reviewed online journal dedicated to precise diagnosis and targeted treatment of cancers and personalized care for patients, encompassing areas of oncology, pathology, imaging, radiotherapy, chemotherapy, surgery, anesthesiology, nursing and etc.